ArticleFrontiers in endocrinology2025
Serum uric acid to creatinine ratio and long-term target vessel events in diabetes patients undergoing PCI with drug-eluting stents implantation: a retrospective study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study aimed to investigate the association between the serum uric acid to creatinine ratio (SUA/Cr) and long-term target vessel events (TVEs) in diabetes mellitus (DM) patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Methods: From July 2009 to August 2011, a total of 2533 patients with coronary heart disease (CHD) who underwent PCI with DES implantation were enrolled to evaluate the relationship between the SUA/Cr and TVEs during a median follow-up of 29.8 months. Multivariable logistic regression and restricted cubic spline analyses were performed, and subgroup analyses were conducted to explore potential effect modifiers. Results: The TVEs were significantly associated with previous male gender (OR=1.58, 95%CI: 1.07~2.32, p=0.021), PCI (OR=3.58, 95% CI: 2.27~5.67, p<0.001),previous stroke(OR=2.19,95%CI:1.24~3.89,p=0.007),triglyceride(OR=1.15, 95%CI:1.06~1.26, p=0.002), length of stent (OR=1.01, 95%CI:1~1.01, p<0.001), and diameter of stent (OR=0.62,95%CI:0.41~0.92,p=0.019). In DM patients, Multivariable logistic regression analyses revealed that higher SUA/Cr was independently associated with a reduced risk of TVEs (adjusted OR=0.72, 95% CI: 0.53-0.97, p=0.031). Restricted cubic spline analysis confirmed a linear inverse relationship between SUA/Cr and TVEs (p for non-linearity=0.782). Subgroup analyses revealed stronger protective effects in non-smokers and non-ST elevation acute coronary syndrome (NSTE-ACS) patients within the DM cohort. Conclusion: A higher SUA/Cr is independently associated with a reduced risk of TVEs in DM patients undergoing PCI with DES. SUA/Cr holds promise as a potential prognostic biomarker for risk stratification in DM patients undergoing PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.